Medical monitoring for pharmaceutical injuries: tort law for the public's health?

David M. Studdert; Michelle M. Mello; Troyen A. Brennan

Commentary

Medical monitoring for pharmaceutical injuries: tort law for the public's health?

February 9, 2011

Studdert DM, Mello MM, Brennan TA. JAMA. 2003;289(7):889-94.

View more articles from the same authors.

PubMed citation

Available at

Related Resources From the Same Author(s)

Disclosure of medical injury to patients: an improbable risk management strategy.

May 20, 2015

Claims, errors, and compensation payments in medical malpractice litigation.

February 17, 2011

Defensive medicine among high-risk specialist physicians in a volatile malpractice environment.

February 3, 2011

"Health courts" and accountability for patient safety.

April 21, 2015

Who pays for medical errors? An analysis of adverse event costs, the medical liability system, and incentives for patient safety improvement.

February 4, 2015

Beyond negligence: avoidability and medical injury compensation.

January 4, 2012

Patient safety and medical malpractice: a case study.

March 2, 2011

Fostering rational regulation of patient safety.

June 23, 2009

The role of medical liability reform in federal health care reform.

January 30, 2017

Advising patients about patient safety: current initiatives risk shifting responsibility.

January 2, 2017

Related Resources

An infrastructure to provide safer, higher quality, and more equitable telehealth.

March 1, 2023

Recommendations for the safe, effective use of adaptive CDS in the US healthcare system: an AMIA position paper.

April 21, 2021

Addressing systemic racism in nursing homes: a time for action.

April 14, 2021

A roadmap to advance patient safety in ambulatory care.

January 20, 2021

Racial disparities in maternal mortality.

January 20, 2021

Conducting safety research safely: a policy-based approach for conducting research with peer review protected material.

January 13, 2021

National drug shortages worsen during COVID-19 crisis: proposal for a comprehensive model to monitor and address critical drug shortages.

November 4, 2020

Cognitive bias and public health policy during the COVID-19 pandemic.

July 22, 2020

Apology laws and malpractice liability: what have we learned?

July 8, 2020

Global drug shortages due to COVID-19: impact on patient care and mitigation strategies.

Medical monitoring for pharmaceutical injuries: tort law for the public's health?

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Medical monitoring for pharmaceutical injuries: tort law for the public's health?

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users